Начало › Рак на белия дроб с недребноклетъчен тип › Кентъки › Louisville
Клинични проучвания за Рак на белия дроб с недребноклетъчен тип в Louisville, KY
22 проучвания за Рак на белия дроб с недребноклетъчен тип търсят участници в обекти в и около Louisville (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
A Study of ZW251 in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- Norton Cancer Institute, Louisville
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Набиране на участнициФаза 1/2
- James Graham Brown Cancer Center (Melanoma/NSCLC), Louisville
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Набиране на участнициФаза 3
- Baptist Health Louisville, Louisville
- Baptist Health Floyd, New Albany · на 4 мили
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Набиране на участнициФаза 3
- Norton Cancer Institute Downtown, Louisville
- Norton Cancer Institute, Downtown, Louisville
- Norton Hospital, Louisville
- и още 4
Pan-tumor MRD Study
Набиране на участнициНаблюдателно проучване
- Baptist Health Louisville, Louisville
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Набиране на участнициФаза 3
- The University of Louisville, James Graham Brown Cancer Center, Louisville
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Набиране на участнициФаза 1
- Norton Cancer Institute, Louisville
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Набиране на участнициФаза 3
- Research Site, Louisville
- Research Site, Louisville
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Набиране на участнициФаза 2/3
- University of Louisville, Louisville
- Local Institution - 007-388-A, Louisville
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Набиране на участнициФаза 1/2
- Norton Cancer Institute Research, Louisville
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Набиране на участнициФаза 1/2
- Norton Cancer Institute PARENT, Louisville
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Набиране на участнициФаза 3
- Research Site, Louisville
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Набиране на участнициФаза 1/2
- Norton Cancer Institute, Louisville
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
Набиране на участнициФаза 1
- Norton Cancer Institute, Louisville
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Набиране на участнициФаза 2
- University of Louisville, Louisville
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Набиране на участнициФаза 1
- Norton Cancer Institute /ID# 248903, Louisville
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
Набиране на участнициФаза 1/2
- University of Louisville, Louisville
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Набиране на участнициФаза 3
- Research Site, Louisville
Study of PF-07248144 in Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 2
- University Medical Center, lnc.:DBA University of Louisville Hospital, Louisville
- University of Louisville, Louisville
- UofL Health Brown Cancer Center, Louisville
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Набиране на участнициФаза 1/2
- Research Site 115, Louisville
A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung Cancer
Набиране на участнициФаза 1
- Research Site, Louisville
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
Набиране на участници
- James Graham Brown Cancer Center, Louisville
Проучвания за Рак на белия дроб с недребноклетъчен тип в други градове
- Houston, TX145 проучвания
- New York City, NY121 проучвания
- Arlington, VA104 проучвания
- Nashville, TN97 проучвания
- Boston, MA90 проучвания
- Los Angeles, CA87 проучвания
- St. Louis, MO73 проучвания
- Chicago, IL61 проучвания
- Baltimore, MD60 проучвания
- San Antonio, TX59 проучвания
- Columbus, OH57 проучвания
- Washington, DC55 проучвания
Други проучвания в Louisville
- Затлъстяване17 проучвания
- Наднормено тегло15 проучвания
- Рак (всички видове)14 проучвания
- Сърдечна недостатъчност13 проучвания
- Остра миелоидна левкемия12 проучвания
- Множествен миелом12 проучвания
- Рак на яйчниците12 проучвания
- Рак на гърдата11 проучвания
- Плоскоклетъчен карцином на главата и шията11 проучвания
- Рак на белия дроб11 проучвания
- Меланом10 проучвания
- Рак на простатата10 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.